{"adverse_reactions":["Sincerus Florida, LLC adverse reactions hn"],"components":["Active, Inactive s"],"effective_time":"20200702","id":"a97a5200-06df-1fad-e053-2a95a90a996d","instructions_for_use":["Directions for use w"],"openfda":{},"package_label_principal_display_panel":["NDC 72934-1211-2 011503 DAPSONE 6% / NIACINAMIDE 2% / SPIRONOLACTONE 5% gel 30 gm d"],"set_id":"a97a5200-06de-1fad-e053-2a95a90a996d","spl_product_data_elements":["011503 DAPSONE 6% / NIACINAMIDE 2% / SPIRONOLACTONE 5% 011503 DAPSONE 6% / NIACINAMIDE 2% / SPIRONOLACTONE 5% NIACINAMIDE NIACINAMIDE SPIRONOLACTONE SPIRONOLACTONE DAPSONE DAPSONE"],"version":"1"}